TACI deficiency enhances antibody avidity and clearance of an intestinal pathogen

Journal of Clinical Investigation

Volumn 124, Issue 11, 2014, Pages 4857-4866

  Tsuji, Shoichiro ^a   Stein, Lucas ^a   Kamada, Nobuhiko ^a   Nuñez, Gabriel ^a   Bram, Richard ^b   Vallance, Bruce A ^c   Sousa, Ana E ^c   Platt, Jeffrey L ^a   Cascalho, Marilia ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b MAYO CLINIC   (United States)

^c UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN; TRANSMEMBRANE ACTIVATOR AND CAML INTERACTOR; BACTERIUM ANTIBODY; TNFRSF13B PROTEIN, MOUSE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN SPECIFICITY; APOPTOSIS; ARTICLE; B LYMPHOCYTE; BLOOD; CITROBACTER RODENTIUM; CONTROLLED STUDY; ENTERITIS; HOST RESISTANCE; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; ADOPTIVE TRANSFER; ANIMAL; ANTIBODY AFFINITY; BIOSYNTHESIS; C57BL MOUSE; CELL CULTURE; CELL PROLIFERATION; DEFICIENCY; ENTEROBACTERIACEAE INFECTION; GENETICS; GERMINAL CENTER; IMMUNOLOGY; KNOCKOUT MOUSE; METABOLISM; MICROBIOLOGY; T LYMPHOCYTE;

ADOPTIVE TRANSFER; ANIMALS; ANTIBODIES, BACTERIAL; ANTIBODY AFFINITY; APOPTOSIS; B-LYMPHOCYTES; CELL PROLIFERATION; CELLS, CULTURED; CITROBACTER RODENTIUM; ENTERITIS; ENTEROBACTERIACEAE INFECTIONS; GERMINAL CENTER; MICE, INBRED C57BL; MICE, KNOCKOUT; T-LYMPHOCYTES; TRANSMEMBRANE ACTIVATOR AND CAML INTERACTOR PROTEIN;

EID: 84908626271     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI74428     Document Type: Article

References (50)

1. von Bulow GU, Bram RJ. NF-AT activation induced by a CAML-interacting member of the tumor necrosis factor receptor superfamily. Science. 1997;278(5335):138-141.
2. Tsuji S, Cortesão C, Bram R, Platt JL, Cascalho M. TACI deficiency impairs sustained Blimp-1 expression in B cells decreasing longlived plasma cells in the bone marrow. Blood. 2011;118(22):5832-5839.
3. Shapiro-Shelef M, Lin KI, McHeyzer-Williams LJ, Liao J, McHeyzer-Williams MG, Calame K. Blimp-1 is required for the formation of immunoglobulin secreting plasma cells and pre-plasma memory B cells. Immunity. 2003;19(4):607-620.
4. Shapiro-Shelef M, Lin KI, Savitsky D, Liao J, Calame K. Blimp-1 is required for maintenance of long-lived plasma cells in the bone marrow. J Exp Med. 2005;202(11):1471-1476.
5. Ou X, Xu S, Lam KP. Deficiency in TNFRSF13B (TACI) expands T-follicular helper and germinal center B cells via increased ICOS-ligand expression but impairs plasma cell survival. Proc Natl Acad Sci USA. 2012;109(38):15401-15406.
6. Mantchev GT, Cortesao C, Rebrovich M, Cascalho M, Bram RJ. TACI is required for efficient plasma cell differentiation in response to T-independent type 2 antigens. J Immunol. 2007;179(4):2282-2288.
7. von Bulow GU, van Deursen JM, Bram RJ. Regulation of the T-independent humoral response by TACI. Immunity. 2001;14(5):573-582.
8. Wolf AI, et al. Protective antiviral antibody responses in a mouse model of influenza virus infection require TACI. J Clin Invest. 2011;121(10):3954-3964.
9. Seshasayee D, Valdez P, Yan M, Dixit VM, Tumas D, Grewal IS. Loss of TACI causes fatal lymphoproliferation and autoimmunity, establishing TACI as an inhibitory BLyS receptor. Immunity. 2003;18(2):279-288.
10. Warnatz K, Voll RE. Pathogenesis of autoimmunity in common variable immunodeficiency. Front Immunol. 2012;3:210.
11. Salzer U, et al. Mutations in TNFRSF13B encoding TACI are associated with common variable immunodeficiency in humans. Nat Genet. 2005;37(8):820-828.
12. Castigli E, et al. TACI is mutant in common variable immunodeficiency and IgA deficiency. Nat Genet. 2005;37(8):829-834.
13. CEREDIH: The French PID study group. The French national registry of primary immunodeficiency diseases. Clin Immunol. 2010;135(2):264-272.
14. Yong PF, Thaventhiran JE, Grimbacher B. "A rose is a rose is a rose, " but CVID is Not CVID common variable immune deficiency (CVID), what do we know in 2011? Adv Immunol. 2011;111:47-107.
15. Resnick ES, Cunningham-Rundles C. The many faces of the clinical picture of common variable immune deficiency. Curr Opin Allergy Clin Immunol. 2012;12(6):595-601.
16. Fried AJ, Rauter I, Dillon SR, Jabara HH, Geha RS. Functional analysis of transmembrane activator and calcium-modulating cyclophilin ligand interactor (TACI) mutations associated with common variable immunodeficiency. J Allergy Clin Immunol. 2011;128(1):226-228.
17. Pan-Hammarstrom Q, et al. Reexamining the role of TACI coding variants in common variable immunodeficiency and selective IgA deficiency. Nat Genet. 2007;39(4):429-430.
18. Salzer U, et al. Relevance of biallelic versus monoallelic TNFRSF13B mutations in distinguishing disease-causing from risk-increasing TNFRSF13B variants in antibody deficiency syndromes. Blood. 2009;113(9):1967-1976.
19. Abecasis GR, et al. An integrated map of genetic variation from 1, 092 human genomes. Nature. 2012;491(7422):56-65.
20. Mohammadi J, et al. Novel mutations in TACI (TNFRSF13B) causing common variable immunodeficiency. J Clin Immunol. 2009;29(6):777-785.
21. Romberg N, et al. CVID-associated TACI mutations affect autoreactive B cell selection and activation. J Clin Invest. 2013;123(10):4283-4293.
22. Koopmans W, Woon ST, Brooks AE, Dunbar PR, Browett P, Ameratunga R. Clinical variability of family members with the C104R mutation in transmembrane activator and calcium modulator and cyclophilin ligand interactor (TACI). J Clin Immunol. 2013;33(1):68-73.
23. Dorner T, Radbruch A. Antibodies and B cell memory in viral immunity. Immunity. 2007;27(3):384-392.
24. AbuAttieh M, Bender D, Liu E, Wettstein P, Platt JL, Cascalho M. Affinity maturation of antibodies requires integrity of the adult thymus. Eur J Immunol. 2012;42(2):500-510.
25. Stevens FJ. Modification of an ELISA-based procedure for affinity determination: correction necessary for use with bivalent antibody. Mol Immunol. 1987;24(10):1055-1060.
26. Allen D, Simon T, Sablitzky F, Rajewsky K, Cumano A. Antibody engineering for the analysis of affinity maturation of an anti-hapten response. EMBO J. 1988;7(7):1995-2001.
27. Shlomchik MJ, Weisel F. Germinal center selection and the development of memory B and plasma cells. Immunol Rev. 2012;247(1):52-63.
28. Kanno Y, Sakurai D, Hase H, Kojima H, Kobata T. TACI induces cIAP1-mediated ubiquitination of NIK by TRAF2 and TANK to limit non-canonical NF-κB signaling. J Recept Signal Transduct Res. 2010;30(2):121-132.
29. Khalil AM, Cambier JC, Shlomchik MJ. B cell receptor signal transduction in the GC is shortcircuited by high phosphatase activity. Science. 2012;336(6085):1178-1181.
30. Goenka R, et al. Local BLyS production by T follicular cells mediates retention of high affinity B cells during affinity maturation. J Exp Med. 2014;211(1):45-56.
31. Xu H, et al. Follicular T-helper cell recruitment governed by bystander B cells and ICOS-driven motility. Nature. 2013;496(7446):523-527.
32. Yee A, De Ravin SS, Elliott E, Ziegler JB. Severe combined immunodeficiency: A national surveillance study. Pediatr Allergy Immunol. 2008;19(4):298-302.
33. Mundy R, MacDonald TT, Dougan G, Frankel G, Wiles S. Citrobacter rodentium of mice and man. Cell Microbiol. 2005;7(12):1697-1706.
34. Bry L, Brenner MB. Critical role of T cell-dependent serum antibody, but not the gut-associated lymphoid tissue, for surviving acute mucosal infection with Citrobacter rodentium, an attaching and effacing pathogen. J Immunol. 2004;172(1):433-441.
35. Ghaem-Maghami M, et al. Intimin-specific immune responses prevent bacterial colonization by the attaching-effacing pathogen Citrobacter rodentium. Infect Immun. 2001;69(9):5597-5605.
36. + T cells in immunity to infection by the attaching and effacing pathogen Citrobacter rodentium. Infect Immun. 2003;71(9):5077-5086.
37. Maaser C, et al. Clearance of Citrobacter rodentium requires B cells but not secretory immunoglobulin A (IgA) or IgM antibodies. Infect Immun. 2004;72(6):3315-3324.
38. Ferreira PC, da Silva JB, Piazza RM, Eckmann L, Ho PL, Oliveira ML. Immunization of mice with Lactobacillus casei expressing a beta-intimin fragment reduces intestinal colonization by Citrobacter rodentium. Clin Vaccine Immunol. 2011;18(11):1823-1833.
39. Chapel H, et al. Common variable immunodeficiency disorders: division into distinct clinical phenotypes. Blood. 2008;112(2):277-286.
40. Martinez-Gallo M, Radigan L, Almejun MB, Martinez-Pomar N, Matamoros N, Cunningham- Rundles C. TACI mutations and impaired B-cell function in subjects with CVID and healthy heterozygotes. J Allergy Clin Immunol. 2013;131(2):468-476.
41. Kayagaki N, et al. Noncanonical inflammasome activation by intracellular LPS independent of TLR4. Science. 2013;341(6151):1246-1249.
42. Cascalho M, Ma A, Lee S, Masat L, Wabl M. A quasi-monoclonal mouse. Science. 1996;272(5268):1649-1652.
43. Giudicelli V, Chaume D, Lefranc MP. IMGT/GENE-DB: A comprehensive database for human and mouse immunoglobulin and T cell receptor genes. Nucleic Acids Res. 2005;33(Database issue):D256-D261.
44. Alamyar E, Giudicelli V, Li S, Duroux P, Lefranc MP. IMGT/HighV-QUEST: The IMGT(R) web portal for immunoglobulin (IG) or antibody and T cell receptor (TR) analysis from NGS high throughput and deep sequencing. Immunome Res. 2012;8(1):26.
45. Friguet B, Chaffotte AF, Djavadi-Ohaniance L, Goldberg ME. Measurements of the true affinity constant in solution of antigen-antibody complexes by enzyme-linked immunosorbent assay. J Immunol Methods. 1985;77(2):305-319.
46. Damm-Ganamet KL, Smith RD, Dunbar JB Jr, Stuckey JA, Carlson HA. CSAR benchmark exercise 2011-2012: evaluation of results from docking and relative ranking of blinded congeneric series. J Chem Inf Model. 2013;53(8):1853-1870.
47. Dunbar JB Jr, et al. CSAR data set release 2012: ligands, affinities, complexes, and docking decoys. J Chem Inf Model. 2013;53(8):1842-1852.
48. Li J, Schantz A, Schwegler M, Shankar G. Detection of low-affinity anti-drug antibodies and improved drug tolerance in immunogenicity testing by Octet((R)) biolayer interferometry. J Pharm Biomed Anal. 2011;54(2):286-294.
49. Kamada N, et al. Regulated virulence controls the ability of a pathogen to compete with the gut microbiota. Science. 2012;336(6086):1325-1329.
50. Naito Y, et al. Germinal center marker GL7 probes activation-dependent repression of N-glycolylneuraminic acid, a sialic acid species involved in the negative modulation of B-cell activation. Mol Cell Biol. 2007;27(8):3008-3022.